Gabapentin ANDA Comparing Tabs To Caps Is Not Complete, Petition Says

An ANDA for gabapentin tablets that references Warner-Lambert's Neurontin capsules should be treated by the agency as "not substantially complete," an Aug. 12 citizen's petition to FDA argues.